BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 20391192)

  • 1. Synthesis and in vitro evaluation of 5-fluoro-6-[(2-iminopyrrolidin-1-YL)methyl]uracil, TPI(F): an inhibitor of human thymidine phosphorylase (TP).
    Grierson JR; Brockenbrough JS; Rasey JS; Wiens L; Vesselle H
    Nucleosides Nucleotides Nucleic Acids; 2010 Jan; 29(1):49-54. PubMed ID: 20391192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure and activity of specific inhibitors of thymidine phosphorylase to potentiate the function of antitumor 2'-deoxyribonucleosides.
    Fukushima M; Suzuki N; Emura T; Yano S; Kazuno H; Tada Y; Yamada Y; Asao T
    Biochem Pharmacol; 2000 May; 59(10):1227-36. PubMed ID: 10736423
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 2: optimization of inhibitors of human thymidine phosphorylase and their selectivity with uridine phosphorylase.
    Yano S; Kazuno H; Sato T; Suzuki N; Emura T; Wierzba K; Yamashita J; Tada Y; Yamada Y; Fukushima M; Asao T
    Bioorg Med Chem; 2004 Jul; 12(13):3443-50. PubMed ID: 15186830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and enzymatic evaluation of pyridinium-substituted uracil derivatives as novel inhibitors of thymidine phosphorylase.
    Murray PE; McNally VA; Lockyer SD; Williams KJ; Stratford IJ; Jaffar M; Freeman S
    Bioorg Med Chem; 2002 Mar; 10(3):525-30. PubMed ID: 11814838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Radiosensitization by thymidine phosphorylase inhibitor in thymidine phosphorylase negative and overexpressing bladder cancer cell lines.
    El-Naggar M; Ebbing E; Bijnsdorp I; van den Berg J; Peters GJ
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):413-21. PubMed ID: 24940699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suppression of metastasis by thymidine phosphorylase inhibitor.
    Takao S; Akiyama SI; Nakajo A; Yoh H; Kitazono M; Natsugoe S; Miyadera K; Fukushima M; Yamada Y; Aikou T
    Cancer Res; 2000 Oct; 60(19):5345-8. PubMed ID: 11034068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel 1-(aryl-aldehyde-oxime)uracil derivatives as a new class of thymidine phosphorylase inhibitors.
    Zhao S; Li K; Jin Y; Lin J
    Eur J Med Chem; 2018 Jan; 144():41-51. PubMed ID: 29247859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and synthesis of novel 5,6-disubstituted uracil derivatives as potent inhibitors of thymidine phosphorylase.
    Nencka R; Votruba I; Hrebabecký H; Tloust'ová E; Horská K; Masojídková M; Holý A
    Bioorg Med Chem Lett; 2006 Mar; 16(5):1335-7. PubMed ID: 16337119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of a thymidine phosphorylase inhibitor on angiogenesis and apoptosis in tumors.
    Matsushita S; Nitanda T; Furukawa T; Sumizawa T; Tani A; Nishimoto K; Akiba S; Miyadera K; Fukushima M; Yamada Y; Yoshida H; Kanzaki T; Akiyama S
    Cancer Res; 1999 Apr; 59(8):1911-6. PubMed ID: 10213500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis and enzymatic evaluation of 6-bridged imidazolyluracil derivatives as inhibitors of human thymidine phosphorylase.
    McNally VA; Rajabi M; Gbaj A; Stratford IJ; Edwards PN; Douglas KT; Bryce RA; Jaffar M; Freeman S
    J Pharm Pharmacol; 2007 Apr; 59(4):537-47. PubMed ID: 17430637
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and evaluation of 6-methylene-bridged uracil derivatives. Part 1: discovery of novel orally active inhibitors of human thymidine phosphorylase.
    Yano S; Kazuno H; Suzuki N; Emura T; Wierzba K; Yamashita J; Tada Y; Yamada Y; Fukushima M; Asao T
    Bioorg Med Chem; 2004 Jul; 12(13):3431-41. PubMed ID: 15186829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of human thymidine phosphorylase in complex with a small molecule inhibitor.
    Norman RA; Barry ST; Bate M; Breed J; Colls JG; Ernill RJ; Luke RW; Minshull CA; McAlister MS; McCall EJ; McMiken HH; Paterson DS; Timms D; Tucker JA; Pauptit RA
    Structure; 2004 Jan; 12(1):75-84. PubMed ID: 14725767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microwave-assisted synthesis and biological evaluation of novel uracil derivatives inhibiting human thymidine phosphorylase.
    Corelli F; Botta M; Lossani A; Pasquini S; Spadari S; Focher F
    Farmaco; 2004 Dec; 59(12):987-92. PubMed ID: 15598434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel nonsubstrate inhibitors of human thymidine phosphorylase, a potential target for tumor-dependent angiogenesis.
    Focher F; Ubiali D; Pregnolato M; Zhi C; Gambino J; Wright GE; Spadari S
    J Med Chem; 2000 Jun; 43(13):2601-7. PubMed ID: 10891120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential tumor-selective nitroimidazolylmethyluracil prodrug derivatives: inhibitors of the angiogenic enzyme thymidine phosphorylase.
    Cole C; Reigan P; Gbaj A; Edwards PN; Douglas KT; Stratford IJ; Freeman S; Jaffar M
    J Med Chem; 2003 Jan; 46(2):207-9. PubMed ID: 12519058
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis of 6-aminouracils and pyrrolo[2,3-d]pyrimidine-2,4-diones and their inhibitory effect on thymidine phosphorylase.
    Hirota K; Sawada M; Sajiki H; Sako M
    Nucleic Acids Symp Ser; 1997; (37):59-60. PubMed ID: 9585998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of Thymidine Phosphorylase Inhibitors in Glioblastoma and Their Capacity for Temozolomide Potentiation.
    Warfield BM; Matheson CJ; McArthur DG; Backos DS; Reigan P
    ACS Chem Neurosci; 2021 Sep; 12(18):3477-3486. PubMed ID: 34472849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aminoimidazolylmethyluracil analogues as potent inhibitors of thymidine phosphorylase and their bioreductive nitroimidazolyl prodrugs.
    Reigan P; Edwards PN; Gbaj A; Cole C; Barry ST; Page KM; Ashton SE; Luke RW; Douglas KT; Stratford IJ; Jaffar M; Bryce RA; Freeman S
    J Med Chem; 2005 Jan; 48(2):392-402. PubMed ID: 15658853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potentiation of the antitumor activity of alpha, alpha, alpha-trifluorothymidine by the co-administration of an inhibitor of thymidine phosphorylase at a suitable molar ratio in vivo.
    Emura T; Suzuki N; Fujioka A; Ohshimo H; Fukushima M
    Int J Oncol; 2005 Aug; 27(2):449-55. PubMed ID: 16010427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activity and substrate specificity of pyrimidine phosphorylases and their role in fluoropyrimidine sensitivity in colon cancer cell lines.
    Temmink OH; de Bruin M; Turksma AW; Cricca S; Laan AC; Peters GJ
    Int J Biochem Cell Biol; 2007; 39(3):565-75. PubMed ID: 17098463
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.